Biocatalytic cascade to DMT derivatives

Biocatalytic cascade to DMT derivatives
Product Description

We developed and patented a combination of enzymes to access N,N-dimethyltryptamine and its derivatives (5-MeO DMT, psilocybin, psilocin, triptans). We look for strategic partnerships to advance the development of this bioprocess. 

Enzyan Biocatalysis GmbH

  • Country/Region:
    Austria
  • On CPHI since:
    2022
  • Employees:
    1 - 24
Company types
Contract Research Organisation (CRO)
Contract Service
Manufacturer/Innovator
Start-up
Primary activities
Agrochemical
Chemical Development
Contract Research Organisation
Fine Chemicals Company
Technology
Specifications
  • Selling Points
    Sustainability
  • Model
    Bioprocess

Enzyan Biocatalysis GmbH

  • Country/Region:
    Austria
  • On CPHI since:
    2022
  • Employees:
    1 - 24
Company types
Contract Research Organisation (CRO)
Contract Service
Manufacturer/Innovator
Start-up
Primary activities
Agrochemical
Chemical Development
Contract Research Organisation
Fine Chemicals Company
Technology

More Products from Enzyan Biocatalysis GmbH (2)

  • Biocatalytic access to chiral amines

    Product Biocatalytic access to chiral amines

    We have a large panel of imine reductases (>140). These enzymes have a large substrate scope catalysing the enantioselective synthesis of chiral amines. We offer access to our panel to customers interested in exploring this chemistry.
  • Biocatalytic access to hydroxylated products

    Product Biocatalytic access to hydroxylated products

    We have a large panel of 2-oxoglutarate dependent enzymes (>150). These enzymes have a large substrate scope catalysing hydroxylation, epoxidation, desaturation, demethylation reactions. We offer access to our panel to customers interested in exploring this chemistry for derivatizaion of your substrates.

Enzyan Biocatalysis GmbH resources (10)